Not applicableStudy completedNCT04476082What this trial is testingNutrition in Gastrointestinal TumorsWho this might be right forPancreatic CancerOesophageal CancerColon Cancer+7 more University Medicine Greifswald 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT04083599What this trial is testingGEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid TumorsWho this might be right forMalignant Solid TumorNon-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)+3 more Genmab 350
Not applicableLooking for participantsNCT07072143What this trial is testingAn International Study on Pediatric Patients With Rare Tumors.Who this might be right forParaganglioma/ PhaeochromocytomaMelanoma and Other Malignant Neoplasms of SkinGastrointestinal Stromal Tumor (GIST)+11 more Azienda Ospedaliera di Padova 6,250
Testing effectiveness (Phase 2)Study completedNCT00587964What this trial is testingPhase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain MetastasesWho this might be right forBrain MetastasisBladder CancerBreast Cancer+10 more Memorial Sloan Kettering Cancer Center 51
Testing effectiveness (Phase 2)Study completedNCT00940225What this trial is testingStudy of Cabozantinib (XL184) in Adults With Advanced MalignanciesWho this might be right forSolid TumorsCancer Exelixis 730
Early research (Phase 1)Ended earlyNCT02714374What this trial is testingGL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ CancersWho this might be right forSolid Organ Cancers Andrew Lowy 5
Early research (Phase 1)Looking for participantsNCT05687123What this trial is testingTesting the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine TumorsWho this might be right forMetastatic Pancreatic Neuroendocrine TumorPancreatic NeoplasmStage III Pancreatic Neuroendocrine Tumor AJCC v8+2 more National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Looking for participantsNCT06172478What this trial is testingHER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorMelanomaHead and Neck Cancer+11 more Daiichi Sankyo 740
Testing effectiveness (Phase 2)Study completedNCT00041808What this trial is testingMagnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the LiverWho this might be right forMetastases, NeoplasmColorectal NeoplasmsEsophageal Neoplasms+9 more FeRx 20
Testing effectiveness (Phase 2)Ended earlyNCT05568017What this trial is testingNeoadjuvant PRRT With Y-90-DOTATOC in pNETWho this might be right forPancreatic Neuroendocrine Tumor European Institute of Oncology 11
Early research (Phase 1)Ended earlyNCT07121829What this trial is testingTovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid TumorsWho this might be right forMelanomaSolid TumorPilocytic Astrocytoma+7 more Day One Biopharmaceuticals, Inc. 44
Testing effectiveness (Phase 2)UnknownNCT03204019What this trial is testingTegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine TumorWho this might be right forPancreatic Neuroendocrine Tumor Chinese Academy of Medical Sciences 60
Early research (Phase 1)Study completedNCT01351103What this trial is testingLGK974 in Patients With Malignancies Dependent on Wnt LigandsWho this might be right forPancreatic CancerBRAF Mutant Colorectal CancerMelanoma+5 more Novartis Pharmaceuticals 185
Not applicableUnknownNCT03033186What this trial is testingEverolimus TDM to Predict Long Term ToxicityWho this might be right forBreast CancerRenal Cell CarcinomaPancreatic Neuroendocrine Tumour+2 more Maastricht University Medical Center 40
Testing effectiveness (Phase 2)Ended earlyNCT03300843What this trial is testingAbility of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous CancerWho this might be right forMelanomaGastrointestinal CancerBreast Cancer+2 more National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Ended earlyNCT03829501What this trial is testingA Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced MalignanciesWho this might be right forSquamous Cell Carcinoma of Head and NeckNon-small Cell Lung CancerHepatocellular Carcinoma+9 more Kymab Limited 222
Not applicableWithdrawnNCT00671463What this trial is testingPancreatic Stent to Prevent Leak After Distal PancreatectomyWho this might be right forPancreatic SurgeryPancreatic Duct StentingPancreatic Cancer+4 more Massachusetts General Hospital
Not applicableLooking for participantsNCT07273409What this trial is testingPancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or NotWho this might be right forPancreatic Neuroendocrine Tumor Uppsala University 200
Not applicableLooking for participantsNCT05837767What this trial is testingRadiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft TissueWho this might be right forInvasive Ductal Breast CarcinomaInvasive Ductal Breast Carcinoma Stage IVLobular Breast Carcinoma+12 more Memorial Sloan Kettering Cancer Center 26
Not applicableLooking for participantsNCT02012699What this trial is testingIntegrated Cancer Repository for Cancer ResearchWho this might be right forPancreatic CancerThyroid CancerLung Cancer+47 more University of Nebraska 999,999